Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,052,312 papers from all fields of science
Search
Sign In
Create Free Account
abnormal cellular structure or growth
Known as:
abnormal structure or growth
, dysplasias
, Dysplastic
Expand
A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns. The cellular changes include nuclear and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
Acanthoma, Clear Cell
Adenomatous Polyposis Coli
Ampulla of Vater Villous Adenoma
Anogenital Papillomaviral Intraepithelial Neoplasia
Expand
Narrower (1)
Cervical dysplasia
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Mathematical estimation of stress distribution in normal and dysplastic human hips
B. Mavčič
,
B. Pompe
,
V. Antolič
,
M. Daniel
,
A. Iglič
,
V. Kralj-Iglič
Journal of Orthopaedic Research
2002
Corpus ID: 17548573
Highly Cited
2002
Highly Cited
2002
A natural history of melanomas and dysplastic nevi
M. Tucker
,
M. Fraser
,
+7 authors
W. Clark
Cancer
2002
Corpus ID: 7335729
Few long‐term clinical and histologic data for melanocytic lesions have been available based on the mutation status of families…
Expand
Highly Cited
2000
Highly Cited
2000
Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.
M. Mori
,
K. Mimori
,
+6 authors
C. Croce
Cancer Research
2000
Corpus ID: 8435438
The FHIT gene, located at chromosome 3p14.2, is a tumor suppressor gene often involved in tumors resulting from exposure to…
Expand
Highly Cited
1997
Highly Cited
1997
Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.
A. Platz
,
Johan Hansson
,
+6 authors
Mats Inganäs
Journal of the National Cancer Institute
1997
Corpus ID: 46199572
BACKGROUND Approximately 10% of human cutaneous melanomas occur in families in which several members are affected. The familial…
Expand
Review
1994
Review
1994
Dysembryoplastic neuroepithelial tumour Features in 16 patients
A. Raymond
,
S. Halpin
,
+9 authors
B. Neville
1994
Corpus ID: 6450396
Dysembryoplastic neuropithelial tumour (DNT) is a newly recognized brain mass lesion with distinctive pathological features and a…
Expand
Highly Cited
1988
Highly Cited
1988
Cytogenetic analysis of melanocytes from premalignant nevi and melanomas.
J. Cowan
,
R. Halaban
,
U. Francke
Journal of the National Cancer Institute
1988
Corpus ID: 23359876
We karyotypically analyzed cultured melanocytes from a variety of lesions, including congenital and dysplastic nevi, primary…
Expand
Highly Cited
1984
Highly Cited
1984
Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
D. J. Ruiter
,
Wilma Bergman
,
+4 authors
S. Ferrane
Cancer Research
1984
Corpus ID: 20823420
Using an indirect immunoperoxidase technique, 20 nevocellular nevi, 5 dysplastic nevi, 14 primary cutaneous melanomas, and 24…
Expand
Highly Cited
1981
Highly Cited
1981
11 Acquired melanocytic nevi and melanoma. The dysplastic nevus syndrome
D. Elder
,
M. Greene
,
E. Bondi
,
W. Clark
,
A. Ackerman
,
Masson
1981
Corpus ID: 79734240
Highly Cited
1976
Highly Cited
1976
Treatment of spondylolisthesis and spondylolysis in children.
L. Wiltse
,
D. Jackson
Clinical Orthopaedics and Related Research
1976
Corpus ID: 7456067
There are 2 fairly common types of spondylolisthesis in children - dysplastic and isthmic. The dysplastic type is secondary to…
Expand
Review
1969
Review
1969
Radiology of bone diseases
G. B. Greenfield
1969
Corpus ID: 70422141
In the preface to the second edition of this substantial work dealing with the radiology of diseases of bone, the author sets…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE